申请人:Pfizer Inc
公开号:US07820648B2
公开(公告)日:2010-10-26
The present invention relates to a compound of the formula 1
or a pharmaceutically acceptable salt thereof, wherein Ar is a group of formula
and R1, R2, R13, A, K, M, L1, L2, X, Y1, Y2, Q, salt thereof, wherein R1, R2, R13, A, K, L1, L2, W, X, Z1, Z2, Y1, Y2, Z1, Z2, M, Q, W, X, m, p and q are as defined herein. Such novel pyrimidine derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. The invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.
本发明涉及一种式子1的化合物或其药学上可接受的盐,其中Ar是式子的一个基团,而R1、R2、R13、A、K、M、L1、L2、X、Y1、Y2、Q、盐等则由本文所定义。这种新型嘧啶衍生物可用于哺乳动物中异常细胞生长的治疗,如癌症。本发明还涉及使用这种化合物治疗哺乳动物尤其是人类异常细胞生长的方法,以及含有这种化合物的药物组合物。